NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Charco Neurotech

Charco Neurotech

Private
CambridgeHealthcare & Life Scienceshttps://charconeurotech.com/

Last Round

Grant

May 24, 2022

Total Funding Raised

$11.19M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Charco Neurotech is a healthcare company that develops non-invasive wearable medical devices to alleviate motor symptoms for people with Parkinson's disease.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT

Business Model

B2C

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Keywords

Parkinson's diseasemedical devicemedtechwearable technologyneurotechvibrotactile stimulationwearable healthtremor managementgait freezingassistive technologydigital healthneurologymovement disordershealth IoTbiohacking

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Charco Neurotech Comparables

Compare Charco Neurotech with similar companies based on industry and business-model similarity.

Charco Neurotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
gaitQ
92%
Encora Therapeutics
83%
Gondola Medical Technologies
82%

Charco Neurotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 24, 2022
SeedNov 16, 2021
Pre SeedMar 17, 2021
Pre SeedFeb 5, 2021

Key People

Founding team and executive leadership

Andrew Mullen

Chief Executive Officer

Executive Team

Charco Neurotech Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 15, 2026

    Monthly visitors grew 52% MoM, reaching 20.3K.

  • Nov 16, 2021

    $10M round led by Amadeus Capital Partners and Parkwalk Advisors.

Charco Neurotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Charco Neurotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Charco Neurotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge
Employee Range73
Year Founded2019
Last FundingMay 24, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.